Evidence map›Paper›PMID 30718519›Full record

Observational studyScientific reports2019

INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatment.

Jiangtao Lin, Xiuhua Fu, Ping Jiang, Weidong Song, Xiaoyun Hu, Zhijun Jie, Chuntao Liu, Zhengguang He, Xiangdong Zhou, Huaping Tang

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02143739 (The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02143739 completednot on this map

The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.

Typeobservational_patient_registrySponsorAstraZenecaRan2014 to 2016Enrolled4,817ConditionsAsthma
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiangtao LinDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. jiangtao_l@263.net.
Xiuhua FuDepartment of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Ping JiangDepartment of Respiratory Diseases, Tianjin First Center Hospital, Tianjin, China.
Weidong SongDepartment of Respiratory Diseases, Peking University Shenzhen Hospital, Shenzhen, China.
Xiaoyun HuDepartment of Respiratory Diseases, The First Affiliated Hospital of Shanxi Medical University, Shanxi, China.
Zhijun JieDepartment of Respiratory Diseases, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
Chuntao LiuDepartment of Respiratory Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zhengguang HeDepartment of Respiratory Diseases, Suining Central Hospital, Suining, China.
Xiangdong ZhouDepartment of Respiratory Diseases, Southwest Hospital, The First Affiliated Hospital of the Third Military Medical University, Chongqing, China.
Huaping TangDepartment of Respiratory Diseases, Qingdao Municipal Hospital, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In China, there are an estimated 30 million people with asthma, a condition that remains poorly controlled in many patients. The INITIAL study (NCT02143739) was a 12-week, multicentre, prospective, observational study comprising 45 centres across Northern and Southern China that aimed to assess asthma severity among newly diagnosed patients as well as their prescribed medications and response to treatment. The primary objective was to evaluate asthma severity using Global Initiative for Asthma (GINA) 2006 research criteria. Secondary objectives included the distribution of asthma medication by GINA severity category and evaluation of GINA 2012-defined control levels. Medications were prescribed as per usual clinical practice. At baseline, among 4491 patients, 3.9%, 12.0%, 22.6% and 61.6% had intermittent, mild persistent, moderate persistent and severe persistent asthma, respectively. Inhaled corticosteroid/long-acting β

Indexed as

Anti-Asthmatic AgentsAsthmaAdministration, InhalationAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAdultDisease ManagementFemaleHumansMaleMiddle AgedProspective StudiesAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic Agents

Identifiers

PMID30718519
PMCPMC6362102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.